Company
Axolbio
Human iPSC-derived cells and specialized services
Also known as Axol Bioscience, Censo Biotechnologies
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- global pharmaceutical companies, contract research organizations (CROs), biotechnology firms, start-ups, and academic institutions
- Legal name
- Censo Biotechnologies
Claim, correct or request removal
Record updated 17 September 2026
About
Axol Bioscience is a leading provider of human induced pluripotent stem cell (iPSC) technologies, specializing in the manufacture of high-performance iPSC-derived cells and the delivery of industry-leading laboratory services. With over a decade of expertise, Axol partners with global pharmaceutical companies, contract research organizations (CROs), biotechnology firms, start-ups, and academic institutions to advance the use of iPSC-based models in drug discovery and disease research.
Funding snapshot
- Total raised
- $2.8MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Undisclosed, $2.8M2026-01-13
Funding rounds
- Round, 2026
- $2.8M2026-01-13, Company stated
Loading relationship preview